Stay up to date with the latest health and social care news from across the UK. From children’s mental health crisis and new inspection guidance for prison education to women’s mental health after childbirth and employment reforms affecting UK employers, discover the stories and developments shaping the sector.
Boots has become the first major UK high street pharmacy chain to launch a medical cannabis prescribing service, marking a significant development in access to treatments for people living with chronic pain, anxiety and insomnia.
The new service, called SureLeaf, launched on Monday 16 November through Boots Online Doctor. It will offer private consultations and prescriptions to eligible patients aged 25 and over who have previously tried conventional treatments without achieving adequate relief from their symptoms.
Patients with conditions including fibromyalgia, arthritis, chronic back pain, migraines, generalised anxiety disorder and insomnia may be eligible for treatment. However, prescriptions will not be issued automatically, and every patient must undergo a specialist clinical assessment before treatment is approved.
The process begins with an online assessment, followed by a video consultation with a specialist doctor. Any proposed prescription must then be independently reviewed by a multidisciplinary clinical team, including a second consultant. Patients will receive a follow-up review after 28 days, with further assessments at least every three months.
Unlike traditional pharmacy services, patients will not be able to collect medical cannabis from their local Boots branch. Prescriptions will be dispensed centrally and delivered directly to patients. The service is entirely private rather than NHS-funded, with an introductory treatment plan costing £89 and ongoing annual care plans available for £99, excluding medication costs.
Medical cannabis has been legal on prescription in the UK since November 2018, although access through the NHS remains extremely limited. Until now, most patients seeking cannabis-based treatments for chronic conditions have relied on specialist private clinics.
Boots Chief Healthcare Officer Jamie Kerruish said the company wanted to provide patients with additional treatment options where conventional medicines had not been successful. The company is also exploring a research partnership with the University of Nottingham to examine patient outcomes and strengthen the evidence surrounding medical cannabis for chronic pain.
However, the announcement comes amid continuing debate about the effectiveness of cannabis-based medicines. Recent research has found insufficient evidence to support their use for several conditions, including some forms of chronic pain and anxiety. Healthcare professionals have emphasised that medical cannabis is not suitable for everyone and requires careful clinical oversight.
For the wider healthcare and social care sectors, the development could lead to more conversations about medical cannabis, particularly among patients living with long-term conditions. Care providers may increasingly encounter people receiving privately prescribed cannabis-based medicines, making accurate medication records, staff awareness and appropriate clinical guidance particularly important.
The launch represents a notable shift in how medical cannabis is accessed in Britain, bringing a treatment previously associated largely with specialist clinics into the services offered by one of the country’s most recognisable pharmacy brands.
Register with The Daily Round for the latest sector news, inspections & reports, wellbeing content, workforce insights, expert features and practical updates—delivered free to your inbox.
Posted by:
M Ramalani
Editorial Assistant – The Daily Round
Busy day? We’ve got you covered. Get FREE daily news, practical insights, opportunities and wellbeing content, carefully curated for busy health and social care professionals. Just enter your details below to get The Daily Briefing delivered straight to your inbox.
Busy day? We’ve got you covered. Get FREE daily news, practical insights, opportunities and wellbeing content, carefully curated for busy health and social care professionals. Just enter your details below to get The Daily Briefing delivered straight to your inbox.